Ellice Marwood

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 118 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

Simon J. Crabb, Gareth Griffiths, Ellice Marwood et al. · Journal of Clinical Oncology · 2020 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

Stuart A. Taylor, Sandy Beare, Gauraang Bhatnagar et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 72 citations · Full text

Medicine, Oncology, Radiology +17

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

Stuart A. Taylor, Simon Ball, Sandy Beare et al. · The Lancet Respiratory Medicine · 2019 · 66 citations · Full text

Medicine, Oncology, Radiology +17

PS01.11 Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial

Dean A. Fennell, Christian H. Ottensmeier, Raffaele Califano et al. · Journal of Thoracic Oncology · 2021 · 34 citations

Medicine, Oncology, Pharmacology +10